Skip to content

Tissue, Blood and Biomarkers to Predict Future Atrial Fibrillation

Tissue, Blood and Biomarkers to Predict Future Atrial Fibrillation - PREDICT AF

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON47800
Enrollment
150
Registered
2014-12-03
Start date
2015-05-12
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation heart rhythm disturbances

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - On-pump surgery - Elective sternotomy for coronary artery bypass grafting or mitral valve surgery or aorta- or aortic valve surgery - CHADS VASC score >= 2 - Sinusrhythm - Age between 18 and 80 years

Exclusion criteria

Exclusion criteria: - Documented or reported history atrial fibrillation, atrial flutter (duration > 5 minutes) or ventricular tachycardia. - Emergency or redo of CABG or valvular surgery - Endocarditis, pericarditis - Active systemic inflammation - active malignancy - NYHA class IV heart failure symptoms - Left ventricular ejection fracton

Design outcomes

Primary

MeasureTime frame
Main study parameters are tissue miRNAs, atrial histopathology and blood biomarkers. Blood biomarkers will include miRNAs and markers of inflammation, oxidative stress, markers of fibrosis formation and circulating microRNAs. These will be correlated to the incidence of post-operative AF and the incidence of newly developed AF after 24 months follow-up. The study will be extended to five years.

Secondary

MeasureTime frame
Additional study parameters on the process of atrial remodeling and clinical data will be collected and include: - Cardiac imaging data - Clinical data on cardiac history - Assessment of stroke-free status - Epicardial mapping during thoracic surgery - Experienced health

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)